title: Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults.
abstract: The present study was undertaken with controls using equal doses ID and IM plus the standard full dose IM to assess the role of route of vaccine in immunogenicity of inactivated influenza vaccine. The study was a prospective, randomized, active-controlled, open label clinical trial conducted in healthy young adult outpatients to compare the effect of route (IM versus ID) on antibody responses to influenza vaccine. Volunteers received 3, 6 or 9 microg of vaccine by ID or IM route; 15 microg IM was also studied. Low doses of vaccine given by either route were almost as immunogenic as the standard 15 microg IM dose of influenza vaccine. ID route was not superior to IM vaccine at inducing antibodies. ID vaccine induced significantly more local inflammatory response than IM vaccine.
authors: Saint Louis University Medical Center, St. Louis, MO 63110, United States. belsherb@slu.edu
authors: Robert B
authors: RB
authors: Belshe
authors: Frances K
authors: FK
authors: Newman
authors: Ken
authors: K
authors: Wilkins
authors: Irene L
authors: IL
authors: Graham
authors: Elizabeth
authors: E
authors: Babusis
authors: Marian
authors: M
authors: Ewell
authors: Sharon E
authors: SE
authors: Frey
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000097:blood / Q000276:immunology; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D006262:Health; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology* / Q000494:pharmacology; D007271:Injections, Intradermal / Q000009:adverse effects; D007273:Injections, Intramuscular / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D017186:Titrimetry
chemical_list: D000914:Antibodies, Viral; D007252:Influenza Vaccines
references: N Engl J Med. 2004 Nov 25;351(22):2295-301
references: 15525714
references: JAMA. 2000 Oct 4;284(13):1655-63
references: 11015795
references: MMWR Recomm Rep. 2006 Jul 28;55(RR-10):1-42
references: 16874296
references: J Am Med Assoc. 1957 Nov 30;165(13):1687-9
references: 13475081
references: N Engl J Med. 1995 Oct 5;333(14):889-93
references: 7666874
references: N Engl J Med. 2004 Nov 25;351(22):2286-94
references: 15525713
references: Clin Infect Dis. 2002 Aug 15;35(4):370-7
references: 12145718
references: Vaccine. 2002 Jan 15;20(7-8):1099-105
references: 11803070
references: Arch Intern Med. 1998 Sep 14;158(16):1769-76
references: 9738606
references: N Engl J Med. 1958 Sep 25;259(13):618-21
references: 13590412
references: Proc Soc Exp Biol Med. 1948 Jan;67(1):96-101
references: 18902305